OPKO Health (NASDAQ: OPK)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-28 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.080 | ||||||
REV | 329.200M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of OPKO Health (NASDAQ: OPK) through any online brokerage.
Other companies in OPKO Health’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Signify Health (NYSE:SGFY), LHC Gr (NASDAQ:LHCG) and Agiliti (NYSE:AGTI).
The latest price target for OPKO Health (NASDAQ: OPK) was reported by Piper Sandler on Tuesday, May 10, 2022. The analyst firm set a price target for 5.00 expecting OPK to rise to within 12 months (a possible 89.39% upside). 2 analyst firms have reported ratings in the last year.
The stock price for OPKO Health (NASDAQ: OPK) is $2.64 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for OPKO Health.
OPKO Health’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for OPKO Health.
OPKO Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.